The effect of low-dose heparin on fibrinopeptide A, platelets, fibrinogen degradation products and other haemostatic parameters measured in connection with intestinal surgery.
D000368:Aged; D001792:Blood Platelets / Q000378:metabolism*; D002986:Clinical Trials as Topic; D003108:Colonic Diseases / Q000601:surgery*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000378:metabolism*; D005340:Fibrinogen / Q000378:metabolism*; D005344:Fibrinopeptide A / Q000097:blood / Q000378:metabolism*; D006487:Hemostasis; D006493:Heparin / Q000097:blood / Q000494:pharmacology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000382:microbiology; D013924:Thrombophlebitis / Q000209:etiology
D005338:Fibrin Fibrinogen Degradation Products; D005344:Fibrinopeptide A; D005340:Fibrinogen; D006493:Heparin